In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice

AD Nahmad, CR Lazzarotto, N Zelikson, T Kustin… - Nature …, 2022 - nature.com
Transplantation of B cells engineered ex vivo to secrete broadly neutralizing antibodies
(bNAbs) has shown efficacy in disease models. However, clinical translation of this …
被引用次数：39 相关文章

In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice.

AD Nahmad, CR Lazzarotto, N Zelikson… - Nature …, 2022 - europepmc.org
Transplantation of B cells engineered ex vivo to secrete broadly neutralizing antibodies
(bNAbs) has shown efficacy in disease models. However, clinical translation of this …
[HTML] nih.gov

[HTML][HTML] In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice

AD Nahmad, CR Lazzarotto, N Zelikson… - Nature …, 2022 - ncbi.nlm.nih.gov
Transplantation of B cells engineered ex vivo to secrete broadly neutralizing antibodies
(bNAbs) has shown efficacy in disease models. However, clinical translation of this …

In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice

AD Nahmad, CR Lazzarotto, N Zelikson… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
Transplantation of B cells engineered ex vivo to secrete broadly neutralizing antibodies
(bNAbs) has shown efficacy in disease models. However, clinical translation of this …

In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice

AD Nahmad, CR Lazzarotto, N Zelikson, T Kustin… - Nature …, 2022 - cris.bgu.ac.il
Transplantation of B cells engineered ex vivo to secrete broadly neutralizing antibodies
(bNAbs) has shown efficacy in disease models. However, clinical translation of this …

In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice

AD Nahmad, CR Lazzarotto, N Zelikson, T Kustin… - paper.sciencenet.cn
Transplantation of B cells engineered ex vivo to secrete broadly neutralizing antibodies
(bNAbs) has shown efficacy in disease models. However, clinical translation of this …
[HTML] nih.gov

[HTML][HTML] In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice

AD Nahmad, CR Lazzarotto, N Zelikson… - Nature …, 2022 - ncbi.nlm.nih.gov
Transplantation of B cells engineered ex vivo to secrete broadly neutralizing antibodies
(bNAbs) has shown efficacy in disease models. However, clinical translation of this …

In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice.

AD Nahmad, CR Lazzarotto, N Zelikson… - Nature …, 2022 - europepmc.org
Transplantation of B cells engineered ex vivo to secrete broadly neutralizing antibodies
(bNAbs) has shown efficacy in disease models. However, clinical translation of this …